The psychedelic drug is at a make-or-break point, with the FDA scheduled to make an announcement this month on whether it is ready to move forward as a PTSD treatment.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
